Company Info
Year Established2019
Ticker
6628
Exchange
HKG
Contacts
Kevin Lin, PhDSenior Director, Business Development U.S.
Company Description
Transcenta is a clinical stage biopharmaceutical company that fully integrates antibody-based biotherapeutics discovery, research, development and manufacturing.